Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy have?
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy has 138 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy published?
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy has 2018 year in the ScholarIQ index.
What is the open-access status of Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy?
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy has bronze oa status in the ScholarIQ index.
What is the DOI of Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy?
The DOI for Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy is on the source record.
What is the PMID of Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy?
The PMID for Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy is on the source record.
What is the OpenAlex record for Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy?
The OpenAlex for Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy is on the source record.